OSAKA, Japan, Feb 21 (Reuters) - Anglo-Swedish drug maker AstraZeneca Plc (AZN.L: Quote, Profile , Research) said on Wednesday it was committed to continued investment in Japan, its second-biggest market, and did not plan to reduce its business in the country despite the recent announcement of global job cuts.
